- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.06. | First Patient Enrolled in New Study Assessing early prediction of flares in Atopic Dermatitis by Castle Biosciences in Collaboration with SciBase | 293 | PR Newswire | STOCKHOLM, June 10, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-powered skin health solutions, today announced that the first patient has been... ► Artikel lesen | |
| 09.06. | SciBase: Study that highlights Nevisense potential for prediction of AD published in leading journal | 327 | PR Newswire | STOCKHOLM, June 9, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-powered skin health solutions, today announced the publication of a study in... ► Artikel lesen | |
| 09.06. | SCIBASE HOLDING AB: Study that highlights Nevisense potential for prediction of AD published in leading journal | 2 | Cision News | ||
| 04.06. | XFRA NEW INSTRUMENTS AVAILABLE ON 04.06.2026 | 193 | Xetra Newsboard | The following instruments on XETRA do have their first trading 04.06.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 04.06.2026
Aktien
1 US53229X1019 Liftoff Mobile Inc.
2... ► Artikel lesen | |
| 03.06. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 03.06.2026 | 643 | Xetra Newsboard | Deletion of Instruments from Boerse Frankfurt - 03.06.2026The following instruments on Boerse Frankfurt do have their last trading day on 03.06.2026.Die folgenden Instrumente in Boerse Frankfurt haben... ► Artikel lesen | |
| 03.06. | XFRA ISIN CHANGE | 299 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA03820A1093 Bullfrog Gold Corp. 03.06.2026 CA12022T1057 Bullfrog Gold Corp. 04.06.2026 Tausch 1:1SE0007045414 SciBase... ► Artikel lesen | |
| 03.06. | XFRA CAPITAL ADJUSTMENT INFORMATION - 03.06.2026 | 285 | Xetra Newsboard | Das Instrument 7V3 SE0006371126 CANTARGIA AB EQUITY wird ex Kapitalmassnahme gehandelt am 03.06.2026 The instrument 7V3 SE0006371126 CANTARGIA AB EQUITY is traded ex capital adjustment on 03.06.2026Das... ► Artikel lesen | |
| 02.06. | Split and Change of ISIN for Scibase Holding AB | 155 | GlobeNewswire | The company will carry out a reverse stock split in a ratio of 1:100. The share will be traded under new ISIN code with effect from Jun 4, 2026. The order book will not change.
Short... ► Artikel lesen | |
| SCIBASE Aktie jetzt für 0€ handeln | |||||
| 28.05. | SciBase announces that the board of directors has resolved on the record date for the reverse share split | 519 | PR Newswire | STOCKHOLM, May 28, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, today announces that the board... ► Artikel lesen | |
| 28.05. | SciBase: Nevisense detects skin barrier damage by chemicals used in household cleaning products in a new ex-vivo study | 473 | PR Newswire | STOCKHOLM, May 28, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, announced today the publication... ► Artikel lesen | |
| 19.05. | Bulletin from the annual general meeting in SciBase Holding AB (publ) | 340 | PR Newswire | STOCKHOLM, May 19, 2026 /PRNewswire/ -- Today, the annual general meeting 2026 has been held in SciBase Holding AB (publ) ("SciBase" or the "Company"). The general meeting resolved in accordance... ► Artikel lesen | |
| 18.05. | SciBase Announces New Research Highlighting Nevisense's Potential in Detecting Age-Related Skin Barrier Changes | 389 | PR Newswire | STOCKHOLM, May 18, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced the presentation... ► Artikel lesen | |
| 07.05. | Scibase Holding AB: Interim report | 175 | GlobeNewswire (Europe) | January 1 - March 31, 2026
The first quarter in figures
Net sales were TSEK 14,278 (8,856), +61%, cleared for currency effects +80%.
The loss after tax was TSEK 24,490 (20,682).
The loss per share... ► Artikel lesen | |
| 27.04. | SciBase publishes the Annual report for 2025 | 292 | PR Newswire | STOCKHOLM, April 27, 2026 /PRNewswire/ -- SciBase hereby announces that the Annual report for 2025 is available at the Company's website www.scibase.com.
A pdf-version of the annual... ► Artikel lesen | |
| 14.04. | Notice to attend the annual general meeting in Scibase Holding AB (publ) | 3 | Cision News | ||
| 07.04. | SciBase reaches milestone with over 400,000 tests sold with Nevisense | 325 | PR Newswire | STOCKHOLM, April 7, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced a significant... ► Artikel lesen | |
| 13.03. | Scibase Holding AB: Interim report | 269 | GlobeNewswire (Europe) | January 1 - December 31, 2025
The fourth quarter in figures
Net sales were TSEK 12,475 (8,598), +45%, cleared for currency effects +57%.
The loss after tax was TSEK 25,300 (21,677).
The loss per... ► Artikel lesen | |
| 10.03. | SciBase: New Study Positions Nevisense's EIS as a valuable and sensitive tool for assessing skin barrier impairment | 462 | PR Newswire | STOCKHOLM, March 10, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, is pleased to announce the publication... ► Artikel lesen | |
| 05.03. | SCIBASE: New Publication: US clinicians' real-world Nevisense experience improves melanoma detection | 3 | Cision News | ||
| 02.03. | SciBase receives approval by FDA for extended labelling in the US | 391 | PR Newswire | STOCKHOLM, March 2, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced that it has received... ► Artikel lesen |
1 2 3 Weiter >>
50 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,100 | +10,13 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy | TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova" or the "Company") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 38,860 | -2,40 % | Truist Cuts Boston Scientific (BSX) 's Target as Doctors Change How They Use Its Heart Device | ||
| PAUL HARTMANN | 205,00 | -0,97 % | Dividendenbekanntmachungen (30.04.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 4IMPRINT GROUP PLC GB0006640972 1,194 GBP 1,3782 EUR AB DYNAMICS PLC GB00B9GQVG73 0,0308 GBP 0,0355 EUR AGNC INVESTMENT CORP US00123Q1040 0... ► Artikel lesen | |
| SYSMEX | 7,304 | -1,62 % | EQS-News: Sysmex Europe SE: Sysmex führt die HISCL Plattform ein, die schnelle, skalierbare Analysen aus Blut für die Alzheimerkrankheit ermöglicht | EQS-News: Sysmex Europe SE
/ Schlagwort(e): Produkteinführung/Sonstiges
Sysmex führt die HISCL Plattform ein, die schnelle, skalierbare Analysen aus Blut für die Alzheimerkrankheit... ► Artikel lesen | |
| ADDLIFE | 14,110 | 0,00 % | Dividendenbekanntmachungen (07.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACCELLERON INDUSTRIES AG ADR US00449R1095 1,8766 USD 1,5973 EUR ACRINOVA AB SE0015660014 3,75 SEK 0,3453 EUR ACRINOVA AB B SE0015660030 3... ► Artikel lesen | |
| EMBECTA | 2,740 | +1,29 % | Embecta Corp.: embecta appoints Nimish Muzumdar as SVP and President, North America | PARSIPPANY, N.J., June 16, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical... ► Artikel lesen | |
| ENOVIS | 19,200 | +0,52 % | Enovis Corporation: Enovis Announces First Quarter 2026 Results | First-quarter sales growth of 5% on a reported basisFirst-quarter Reconstructive sales grew 11% on a reported basisReiterating full-year 2026 revenue, adjusted EBITDA, adjusted EPS, and Free Cash... ► Artikel lesen | |
| SI-BONE | 13,500 | -0,74 % | SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance | First Quarter 2026 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $52.6 million, representing growth of 11.2%U.S. revenue of $49.3 million, representing growth... ► Artikel lesen | |
| PULMONX | 1,100 | 0,00 % | Pulmonx Corporation: Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results | REDWOOD CITY, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported... ► Artikel lesen | |
| REVITALIST LIFESTYLE AND WELLNESS | 0,015 | -100,00 % | Revitalist Lifestyle and Wellness Ltd: Revitalist Lifestyle CEO Walker, CFO Murray resign | ||
| KOOTH | 1,830 | +3,98 % | Kooth Digital Health Names Fred Bendaña Chief Commercial Officer | Chicago, May 21, 2026 (GLOBE NEWSWIRE) -- Kooth Digital Health announced the appointment of Fred Bendaña as Chief Commercial Officer, a role that will accelerate the growth of Soluna, Kooth's digital... ► Artikel lesen | |
| PEIJIA MEDICAL | 0,430 | -0,92 % | Peijia Medical Announces 2025 Annual Results | SUZHOU, China, March 26, 2026 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and... ► Artikel lesen | |
| LIFECARE ASA | 0,013 | -56,67 % | Lifecare ASA: Share capital increase registered | ||
| BACTIGUARD | 1,345 | 0,00 % | Bactiguard Holding AB: Bulletin from Bactiguard Holding AB's (publ) Annual General Meeting | At Bactiguard Holding AB's (publ) Annual General Meeting (AGM) on 19 May 2026, the following resolutions were made:
The AGM adopted the income statements and balance sheets for 2025 and decided that... ► Artikel lesen | |
| PHC HOLDINGS | 5,300 | -2,75 % | Dividendenbekanntmachungen (30.03.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 77 BANK LTD JP3352000008 113 JPY 0,6124 EUR ACOM CO LTD JP3108600002 10 JPY 0,0542 EUR ADAMAS TRUST INC US6496048405 0,23 USD 0... ► Artikel lesen |
Das Unternehmen SCIBASE HOLDING AB kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,595 (-15,04 %) liegt der Kurs bei 3,360 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SCIBASE HOLDING AB finden Sie auf Wallstreet Online.